News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
768,019 Results
Type
Article (71773)
Company Profile (144)
Press Release (696086)
Multimedia
Podcasts (154)
Webinars (23)
Section
Business (196724)
Career Advice (3082)
Deals (36101)
Drug Delivery (142)
Drug Development (83984)
Employer Resources (173)
FDA (16917)
Job Trends (15971)
News (343950)
Policy (34261)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (3001)
Academic (2)
Accelerated approval (40)
Adcomms (33)
Allergies (165)
Alliances (48853)
ALS (192)
Alzheimer's disease (1784)
Antibody-drug conjugate (ADC) (345)
Approvals (17187)
Artificial intelligence (612)
Autoimmune disease (204)
Automation (45)
Bankruptcy (352)
Best Places to Work (12163)
BIOSECURE Act (21)
Biosimilars (204)
Biotechnology (95)
Bladder cancer (172)
Brain cancer (69)
Breast cancer (685)
Cancer (5204)
Cardiovascular disease (455)
Career advice (2633)
Career pathing (44)
CAR-T (306)
CDC (56)
Celiac Disease (2)
Cell therapy (822)
Cervical cancer (41)
Clinical research (71632)
Collaboration (1875)
Company closure (5)
Compensation (923)
Complete response letters (75)
COVID-19 (2883)
CRISPR (108)
C-suite (978)
Cystic fibrosis (156)
Data (6751)
Decentralized trials (2)
Denatured (50)
Depression (160)
Diabetes (529)
Diagnostics (7042)
Digital health (50)
Diversity (13)
Diversity, equity & inclusion (43)
Drug discovery (292)
Drug pricing (214)
Drug shortages (32)
Duchenne muscular dystrophy (252)
Earnings (77211)
Editorial (66)
Employer branding (23)
Employer resources (154)
Events (129866)
Executive appointments (1075)
FDA (20295)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1606)
Gene editing (224)
Generative AI (53)
Gene therapy (656)
GLP-1 (1079)
Government (5202)
Grass and pollen (8)
Guidances (387)
Healthcare (20240)
HIV (73)
Huntington's disease (49)
IgA nephropathy (90)
Immunology and inflammation (273)
Immuno-oncology (76)
Indications (139)
Infectious disease (3184)
Inflammatory bowel disease (210)
Inflation Reduction Act (15)
Influenza (126)
Intellectual property (269)
Interviews (571)
IPO (16827)
IRA (54)
Job creations (4130)
Job search strategy (2169)
JPM (70)
Kidney cancer (19)
Labor market (84)
Layoffs (630)
Leadership (42)
Legal (8180)
Liver cancer (95)
Longevity (21)
Lung cancer (696)
Lymphoma (390)
Machine learning (46)
Management (59)
Manufacturing (867)
MASH (179)
Medical device (14928)
Medtech (14996)
Mergers & acquisitions (20426)
Metabolic disorders (1408)
mRNA (189)
Multiple sclerosis (171)
NASH (17)
Neurodegenerative disease (364)
Neuropsychiatric disorders (100)
Neuroscience (3158)
Neurotech (1)
NextGen: Class of 2026 (7126)
Non-profit (4859)
Now hiring (52)
Obesity (671)
Opinion (331)
Ovarian cancer (172)
Pain (230)
Pancreatic cancer (249)
Parkinson's disease (320)
Partnered (35)
Patents (542)
Patient recruitment (566)
Peanut (65)
People (63827)
Pharmaceutical (31)
Pharmacy benefit managers (29)
Phase 1 (22345)
Phase 2 (31409)
Phase 3 (23289)
Pipeline (6256)
Policy (331)
Postmarket research (2888)
Preclinical (9821)
Press Release (68)
Prostate cancer (270)
Psychedelics (52)
Radiopharmaceuticals (310)
Rare diseases (971)
Real estate (6530)
Recruiting (73)
Regulatory (25765)
Reports (44)
Research institute (2660)
Resumes & cover letters (481)
Rett syndrome (31)
RNA editing (18)
RSV (82)
Schizophrenia (162)
Series A (271)
Series B (199)
Service/supplier (11)
Sickle cell disease (105)
Special edition (25)
Spinal muscular atrophy (180)
Sponsored (47)
Startups (3840)
State (1)
Stomach cancer (16)
Supply chain (110)
Tariffs (86)
The Weekly (101)
Vaccines (1099)
Venture capital (97)
Weight loss (447)
Women's health (99)
Worklife (23)
Date
Today (138)
Last 7 days (701)
Last 30 days (3112)
Last 365 days (30938)
2026 (6082)
2025 (31135)
2024 (35764)
2023 (40903)
2022 (52166)
2021 (56998)
2020 (55962)
2019 (49907)
2018 (37859)
2017 (34037)
2016 (34287)
2015 (40243)
2014 (33547)
2013 (29794)
2012 (31615)
2011 (31744)
2010 (30610)
Location
Africa (1001)
Alabama (91)
Alaska (7)
Arizona (300)
Arkansas (15)
Asia (44977)
Australia (7936)
California (11650)
Canada (3418)
China (1202)
Colorado (495)
Connecticut (502)
Delaware (353)
Europe (103609)
Florida (1763)
Georgia (388)
Hawaii (3)
Idaho (63)
Illinois (995)
India (77)
Indiana (545)
Iowa (22)
Japan (454)
Kansas (131)
Kentucky (46)
Louisiana (35)
Maine (85)
Maryland (1455)
Massachusetts (8425)
Michigan (358)
Minnesota (680)
Mississippi (7)
Missouri (145)
Montana (36)
Nebraska (29)
Nevada (134)
New Hampshire (88)
New Jersey (3194)
New Mexico (32)
New York (3118)
North Carolina (1581)
North Dakota (10)
Northern California (5639)
Ohio (371)
Oklahoma (23)
Oregon (44)
Pennsylvania (2345)
Puerto Rico (25)
Rhode Island (50)
South America (1343)
South Carolina (72)
South Dakota (1)
Southern California (4644)
Tennessee (194)
Texas (1893)
United States (42101)
Utah (370)
Vermont (1)
Virginia (294)
Washington D.C. (79)
Washington State (972)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
768,019 Results for "university of texas medical branch at galveston".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
ChemDiv Forges Strategic Partnership with The University of Texas Medical Branch (UTMB) to Expand Its High-throughput Screening Research Capabilities
ChemDiv announces a strategic collaboration with the University of Texas Medical Branch to facilitate the expansion of its inventory and advance the institution’s High-throughput Screening research programs.
December 28, 2023
·
1 min read
Press Releases
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
March 4, 2026
·
3 min read
Press Releases
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
December 11, 2025
·
6 min read
Press Releases
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to implant FDA-approved novel defibrillation lead
February 3, 2026
·
2 min read
Legal
Texas Accuses Lilly of ‘Bribing’ Prescribers To Push Mounjaro, Zepbound in New Suit
Texas Attorney General Ken Paxton claims that through an alleged kickback scheme Eli Lilly “fraudulently sought to maximize profits at taxpayer expense.”
August 13, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
Milestone Scientific Inc. Announces Entrée into the Nationally Recognized University of Texas Medical Branch at Galveston with its CompuFlo Disposables
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that as per a purchase order the Company received in late 2020, it has begun selling CompuFlo® disposables to the University of Texas Medical Branch at Galveston (UTMB), an institution of the University of Texas System and agency of the State of Texas. UTMB is a
January 4, 2021
·
6 min read
Press Releases
Targeted Genomics Launches Celiac Genetic Testing Services for Texas Physicians
February 2, 2026
·
2 min read
Job Trends
6 Companies Hiring in Texas
Looking for a biopharma job in Texas? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
August 14, 2025
·
1 min read
·
Angela Gabriel
Business
Sorrento and The University of Texas medical branch at Galveston enter into preclinical testing agreement for COVID-19 therapeutic candidates
Sorrento Therapeutics, Inc., announced it has entered into a research testing agreement with The University of Texas Medical Branch at Galveston for the preclinical testing of Sorrento’s COVID-19 therapeutic product candidates.
March 31, 2020
·
6 min read
Manufacturing
Novartis Names Texas City as Location of Its 5th US Radiopharmaceutical Facility
The Denton site is part of a network of manufacturing plants Novartis is building across the U.S. to make cancer drugs that must be shipped to patients quickly.
February 25, 2026
·
2 min read
·
Nick Paul Taylor
1 of 76,802
Next